Role of Group 1 CD1-Restricted T Cells in Host Defense and Inflammatory Diseases.
Journal
Critical reviews in immunology
ISSN: 1040-8401
Titre abrégé: Crit Rev Immunol
Pays: United States
ID NLM: 8914819
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
5
4
2022
pubmed:
1
1
2021
medline:
8
4
2022
Statut:
ppublish
Résumé
Group 1 CD1-restricted T cells are members of the unconventional T cell family that recognize lipid antigens presented by CD1a, CD1b, and CD1c molecules. Although they developmentally mirror invariant natural killer T cells, they have diverse antigen specificity and functional capacity, with both anti-microbial and autoreactive targets. The role of group 1 CD1-restricted T cells has been best established in Mycobacterium tuberculosis (Mtb) infection in which a wide variety of lipid antigens have been identified and their ability to confer protection against Mtb infection in a CD1 transgenic mouse model has been shown. Group 1 CD1-restricted T cells have also been implicated in other infections, inflammatory conditions, and malignancies. In particular, autoreactive group 1 CD1-restricted T cells have been shown to play a role in several skin inflammatory conditions. The prevalence of group 1 CD1 autoreactive T cells in healthy individuals suggests the presence of regulatory mechanisms to suppress autoreactivity in homeostasis. The more recent use of group 1 CD1 tetramers and mouse models has allowed for better characterization of their phenotype, functional capacity, and underlying mechanisms of antigen-specific and autoreactive activation. These discoveries may pave the way for the development of novel vaccines and immunotherapies that target group 1 CD1-restricted T cells.
Identifiants
pubmed: 35381140
pii: 256bb987559bc247,291c234038b20587
doi: 10.1615/CritRevImmunol.2021040089
pmc: PMC10128144
mid: NIHMS1888845
doi:
Substances chimiques
Antigens, CD1
0
Lipids
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-21Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM008152
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI146072
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI057460
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI057460
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145345
Pays : United States
Références
Eur J Immunol. 1989 Feb;19(2):285-92
pubmed: 2467814
Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):201-214
pubmed: 28386696
Front Immunol. 2018 Jan 09;8:1950
pubmed: 29375573
Nat Immunol. 2014 Feb;15(2):177-85
pubmed: 24362891
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):380-5
pubmed: 26621732
Front Immunol. 2018 Jun 28;9:1478
pubmed: 30013556
J Immunol. 2010 Feb 1;184(3):1235-41
pubmed: 20026739
Int J Epidemiol. 1993 Dec;22(6):1154-8
pubmed: 8144299
Am J Respir Crit Care Med. 2016 Aug 1;194(3):345-55
pubmed: 26882070
Vaccine. 2009 Jul 30;27(35):4818-25
pubmed: 19538998
J Exp Med. 2004 Mar 1;199(5):649-59
pubmed: 14981115
Int J Environ Res Public Health. 2019 Nov 27;16(23):
pubmed: 31783478
Nature. 1992 Dec 10;360(6404):593-7
pubmed: 1281285
Hum Pathol. 2001 Aug;32(8):803-7
pubmed: 11521223
Vet Immunol Immunopathol. 2011 Aug 15;142(3-4):265-70
pubmed: 21640388
J Clin Invest. 2020 Jan 2;130(1):214-230
pubmed: 31763997
Nat Immunol. 2016 Oct;17(10):1159-66
pubmed: 27548435
Nat Immunol. 2010 Dec;11(12):1102-9
pubmed: 21037579
Am J Pathol. 2004 Dec;165(6):1853-63
pubmed: 15579430
Elife. 2015 Dec 10;4:
pubmed: 26652001
Mol Immunol. 2018 Dec;104:27-36
pubmed: 30399491
J Immunol. 2014 May 1;192(9):4054-60
pubmed: 24683194
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33393500
Immunity. 1998 Mar;8(3):331-40
pubmed: 9529150
Chem Biol. 2009 Jan 30;16(1):82-92
pubmed: 19171308
Mol Immunol. 2021 Feb;130:159-163
pubmed: 33384157
Annu Rev Immunol. 2004;22:817-90
pubmed: 15032598
Sci Transl Med. 2016 Feb 10;8(325):325ra18
pubmed: 26865566
J Immunol. 2002 Jul 1;169(1):330-9
pubmed: 12077262
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1266-75
pubmed: 26884207
J Immunol. 2000 Nov 1;165(9):5338-44
pubmed: 11046069
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17755-60
pubmed: 22006319
Front Immunol. 2020 Nov 18;11:610010
pubmed: 33312179
J Invest Dermatol. 2003 Sep;121(3):517-21
pubmed: 12925210
J Exp Med. 2011 Aug 29;208(9):1741-7
pubmed: 21807869
Mediators Inflamm. 2020 Apr 19;2020:8745863
pubmed: 32377167
Eur J Immunol. 2017 Jul;47(7):1171-1180
pubmed: 28440548
J Exp Med. 2016 Oct 17;213(11):2399-2412
pubmed: 27670592
Science. 1995 Jul 14;269(5221):227-30
pubmed: 7542404
Cell Immunol. 2019 Jan;335:59-67
pubmed: 30392891
J Lipid Res. 2018 Aug;59(8):1367-1373
pubmed: 29559523
Oncoimmunology. 2016 Jul 22;5(9):e1213932
pubmed: 27757307
Nat Commun. 2019 Jan 4;10(1):56
pubmed: 30610190
J Exp Med. 2015 Feb 9;212(2):149-63
pubmed: 25584012
Inflamm Bowel Dis. 2018 May 18;24(6):1225-1236
pubmed: 29788291
Science. 2004 Jan 23;303(5657):527-31
pubmed: 14739458
Sci Immunol. 2017 Dec 22;2(18):
pubmed: 29273672
Health Technol Assess. 2017 Jul;21(39):1-54
pubmed: 28738015
J Exp Med. 2004 Dec 20;200(12):1559-69
pubmed: 15611286
Glycobiology. 2012 Aug;22(8):1118-27
pubmed: 22534567
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13230-5
pubmed: 21788486
Nat Rev Immunol. 2015 Oct;15(10):643-54
pubmed: 26388332
Nat Immunol. 2003 Aug;4(8):808-15
pubmed: 12833155
Science. 1997 Oct 10;278(5336):283-6
pubmed: 9323206
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10956-E10964
pubmed: 29158404
Pathol Res Pract. 2015 Sep;211(9):652-6
pubmed: 26073685
Curr Top Microbiol Immunol. 2007;314:113-41
pubmed: 17593659
Mol Immunol. 2021 Feb;130:14-19
pubmed: 33348245
Blood. 2013 Aug 8;122(6):932-42
pubmed: 23794066
J Immunol. 2005 Mar 15;174(6):3773-80
pubmed: 15749918
J Immunol Methods. 2000 Apr 21;238(1-2):119-31
pubmed: 10758242
Cancer Immunol Immunother. 2007 Apr;56(4):563-72
pubmed: 16924493
Sci Immunol. 2020 Jan 3;5(43):
pubmed: 31901073
Infect Immun. 2013 Jan;81(1):311-6
pubmed: 23132493
Front Immunol. 2020 Feb 14;11:199
pubmed: 32117314
Immunology. 2008 Nov;125(3):289-301
pubmed: 18445008
Am J Surg Pathol. 2012 May;36(5):732-6
pubmed: 22498823
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22944-22952
pubmed: 32868441
J Exp Med. 2014 Jun 30;211(7):1363-77
pubmed: 24935257
Eur J Immunol. 2011 Mar;41(3):602-10
pubmed: 21246542
Nature. 1994 Dec 15;372(6507):691-4
pubmed: 7527500
Eur J Immunol. 2008 Aug;38(8):2351-9
pubmed: 18624350
Blood. 1988 Jul;72(1):241-7
pubmed: 3260523
J Clin Invest. 2004 Mar;113(5):701-8
pubmed: 14991068
Blood. 2011 Oct 6;118(14):3870-8
pubmed: 21860021
Sci Rep. 2021 Feb 18;11(1):4106
pubmed: 33602992
J Immunol. 2018 Aug 1;201(3):888-896
pubmed: 29914888
Front Immunol. 2020 Oct 14;11:566710
pubmed: 33162982
Nature. 1989 Oct 5;341(6241):447-50
pubmed: 2477705
Nat Immunol. 2002 Aug;3(8):721-6
pubmed: 12118248
J Immunol. 2013 Nov 1;191(9):4499-503
pubmed: 24089190
Eur J Immunol. 2019 May;49(5):737-746
pubmed: 30854633
J Clin Invest. 2017 Jun 1;127(6):2339-2352
pubmed: 28463230
Blood. 2007 Jan 15;109(2):643-52
pubmed: 16968896
Pathol Oncol Res. 2020 Jul;26(3):1687-1695
pubmed: 31606786
J Exp Med. 2021 Jul 5;218(7):
pubmed: 33961028
J Immunol. 2021 Mar 15;206(6):1240-1250
pubmed: 33536255
Cell Chem Biol. 2018 Apr 19;25(4):392-402.e14
pubmed: 29398561
J Biol Chem. 2011 Oct 14;286(41):35438-35446
pubmed: 21859718
Semin Cell Dev Biol. 2018 Dec;84:48-57
pubmed: 29113870
Immunity. 1999 Dec;11(6):743-52
pubmed: 10626896
Sci Rep. 2021 Jan 21;11(1):2010
pubmed: 33479373
PLoS Pathog. 2020 Apr 28;16(4):e1008443
pubmed: 32343740
Blood. 2019 May 23;133(21):2291-2304
pubmed: 30796021
Biochem J. 2019 Jul 18;476(14):1995-2016
pubmed: 31320388
J Biol Chem. 2012 Sep 7;287(37):31494-502
pubmed: 22782895
Immunity. 2010 Dec 14;33(6):853-62
pubmed: 21167756
J Exp Med. 2009 Oct 26;206(11):2497-509
pubmed: 19808251
J Immunol. 2016 Feb 15;196(4):1933-42
pubmed: 26755823
J Exp Med. 2013 Apr 8;210(4):729-41
pubmed: 23530121
J Immunol. 1989 Apr 15;142(8):2714-20
pubmed: 2467935
EMBO J. 2006 Aug 9;25(15):3684-92
pubmed: 16874306
Nat Immunol. 2013 Jul;14(7):706-13
pubmed: 23727893
Cell Chem Biol. 2016 Sep 22;23(9):1147-1156
pubmed: 27662254
Histopathology. 2018 May;72(6):905-913
pubmed: 29023924
Eur J Immunol. 2017 Sep;47(9):1525-1534
pubmed: 28665555
Nat Immunol. 2018 Apr;19(4):397-406
pubmed: 29531339
Nat Commun. 2016 Oct 27;7:13257
pubmed: 27807341
J Neuroimmunol. 1996 Jul;67(2):145-51
pubmed: 8765339
Scand J Immunol. 2000 Apr;51(4):377-83
pubmed: 10736110
Oncol Lett. 2018 Apr;15(4):5087-5092
pubmed: 29552142
Tissue Antigens. 2015 Dec;86(6):393-405
pubmed: 26514448
J Immunol Methods. 2018 Jul;458:44-52
pubmed: 29684428
J Clin Invest. 2011 Jun;121(6):2493-503
pubmed: 21576820
Front Immunol. 2018 Nov 27;9:2709
pubmed: 30538700
J Invest Dermatol. 2022 Mar;142(3 Pt B):768-773
pubmed: 34130802